 | • レポートコード：GIR-105X01347 • 出版社/出版日：GlobalInfoResearch / 2021年5月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、オータコイド＆関連薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。オータコイド＆関連薬の種類別市場規模（ポリペプチド、脱炭酸アミノ酸、エイコサノイド）、用途別市場規模（アレルギー、炎症、胃酸分泌、神経内分泌規制、慢性疼痛、循環器疾患、胃腸疾患）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・オータコイド＆関連薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bedford Laboratories、Bristol-Myers Squibb、APP Pharma、Abbott Laboratories、Sanofi、Chattem、Xanodyne、AstraZeneca、Hospira ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ポリペプチド、脱炭酸アミノ酸、エイコサノイド ・用途別分析2016年-2026年：アレルギー、炎症、胃酸分泌、神経内分泌規制、慢性疼痛、循環器疾患、胃腸疾患 ・オータコイド＆関連薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・オータコイド＆関連薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・オータコイド＆関連薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・オータコイド＆関連薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・オータコイド＆関連薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Autacoids and Related Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Autacoids and Related Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Autacoids and Related Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Autacoids and Related Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Polypeptides
Decarboxylated Amino Acids
Eicosanoids
Market segment by Application can be divided into
Allergies
Inflammation
Gastric Acid Secretion
Neuroendocrine Regulation
Chronic Pain
Cardiovascular Diseases
Gastrointestinal Diseases
The key market players for global Autacoids and Related Drugs market are listed below:
Bedford Laboratories
Bristol-Myers Squibb
APP Pharma
Abbott Laboratories
Sanofi
Chattem
Xanodyne
AstraZeneca
Hospira
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Autacoids and Related Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Autacoids and Related Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Polypeptides
1.2.3 Decarboxylated Amino Acids
1.2.4 Eicosanoids
1.3 Market Analysis by Application
1.3.1 Overview: Global Autacoids and Related Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Allergies
1.3.3 Inflammation
1.3.4 Gastric Acid Secretion
1.3.5 Neuroendocrine Regulation
1.3.6 Chronic Pain
1.3.7 Cardiovascular Diseases
1.3.8 Gastrointestinal Diseases
1.4 Global Autacoids and Related Drugs Market Size & Forecast
1.4.1 Global Autacoids and Related Drugs Sales in Value (2016-2026))
1.4.2 Global Autacoids and Related Drugs Sales in Volume (2016-2026)
1.4.3 Global Autacoids and Related Drugs Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Autacoids and Related Drugs Production Capacity Analysis
1.5.1 Global Autacoids and Related Drugs Total Production Capacity (2016-2026)
1.5.2 Global Autacoids and Related Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Autacoids and Related Drugs Market Drivers
1.6.2 Autacoids and Related Drugs Market Restraints
1.6.3 Autacoids and Related Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Bedford Laboratories
2.1.1 Bedford Laboratories Details
2.1.2 Bedford Laboratories Major Business
2.1.3 Bedford Laboratories Autacoids and Related Drugs Product and Services
2.1.4 Bedford Laboratories Autacoids and Related Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Bristol-Myers Squibb
2.2.1 Bristol-Myers Squibb Details
2.2.2 Bristol-Myers Squibb Major Business
2.2.3 Bristol-Myers Squibb Autacoids and Related Drugs Product and Services
2.2.4 Bristol-Myers Squibb Autacoids and Related Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 APP Pharma
2.3.1 APP Pharma Details
2.3.2 APP Pharma Major Business
2.3.3 APP Pharma Autacoids and Related Drugs Product and Services
2.3.4 APP Pharma Autacoids and Related Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Abbott Laboratories
2.4.1 Abbott Laboratories Details
2.4.2 Abbott Laboratories Major Business
2.4.3 Abbott Laboratories Autacoids and Related Drugs Product and Services
2.4.4 Abbott Laboratories Autacoids and Related Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Autacoids and Related Drugs Product and Services
2.5.4 Sanofi Autacoids and Related Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Chattem
2.6.1 Chattem Details
2.6.2 Chattem Major Business
2.6.3 Chattem Autacoids and Related Drugs Product and Services
2.6.4 Chattem Autacoids and Related Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Xanodyne
2.7.1 Xanodyne Details
2.7.2 Xanodyne Major Business
2.7.3 Xanodyne Autacoids and Related Drugs Product and Services
2.7.4 Xanodyne Autacoids and Related Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business
2.8.3 AstraZeneca Autacoids and Related Drugs Product and Services
2.8.4 AstraZeneca Autacoids and Related Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Hospira
2.9.1 Hospira Details
2.9.2 Hospira Major Business
2.9.3 Hospira Autacoids and Related Drugs Product and Services
2.9.4 Hospira Autacoids and Related Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Autacoids and Related Drugs Sales by Manufacturer
3.1 Global Autacoids and Related Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Autacoids and Related Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Autacoids and Related Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Autacoids and Related Drugs Manufacturer Market Share
3.4.2 Top 6 Autacoids and Related Drugs Manufacturer Market Share
3.5 Global Autacoids and Related Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Autacoids and Related Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Autacoids and Related Drugs Market Size by Region
4.1.1 Global Autacoids and Related Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Autacoids and Related Drugs Revenue by Region (2016-2026)
4.2 North America Autacoids and Related Drugs Revenue (2016-2026)
4.3 Europe Autacoids and Related Drugs Revenue (2016-2026)
4.4 Asia-Pacific Autacoids and Related Drugs Revenue (2016-2026)
4.5 South America Autacoids and Related Drugs Revenue (2016-2026)
4.6 Middle East and Africa Autacoids and Related Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Autacoids and Related Drugs Sales in Volume by Type (2016-2026)
5.2 Global Autacoids and Related Drugs Revenue by Type (2016-2026)
5.3 Global Autacoids and Related Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Autacoids and Related Drugs Sales in Volume by Application (2016-2026)
6.2 Global Autacoids and Related Drugs Revenue by Application (2016-2026)
6.3 Global Autacoids and Related Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Autacoids and Related Drugs Sales by Type (2016-2026)
7.2 North America Autacoids and Related Drugs Sales by Application (2016-2026)
7.3 North America Autacoids and Related Drugs Market Size by Country
7.3.1 North America Autacoids and Related Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Autacoids and Related Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Autacoids and Related Drugs Sales by Type (2016-2026)
8.2 Europe Autacoids and Related Drugs Sales by Application (2016-2026)
8.3 Europe Autacoids and Related Drugs Market Size by Country
8.3.1 Europe Autacoids and Related Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Autacoids and Related Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Autacoids and Related Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Autacoids and Related Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Autacoids and Related Drugs Market Size by Region
9.3.1 Asia-Pacific Autacoids and Related Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Autacoids and Related Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Autacoids and Related Drugs Sales by Type (2016-2026)
10.2 South America Autacoids and Related Drugs Sales by Application (2016-2026)
10.3 South America Autacoids and Related Drugs Market Size by Country
10.3.1 South America Autacoids and Related Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Autacoids and Related Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Autacoids and Related Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Autacoids and Related Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Autacoids and Related Drugs Market Size by Country
11.3.1 Middle East & Africa Autacoids and Related Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Autacoids and Related Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Autacoids and Related Drugs Typical Distributors
12.3 Autacoids and Related Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Autacoids and Related Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Autacoids and Related Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Bedford Laboratories Basic Information, Manufacturing Base and Competitors
Table 4. Bedford Laboratories Major Business
Table 5. Bedford Laboratories Autacoids and Related Drugs Product and Services
Table 6. Bedford Laboratories Autacoids and Related Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 8. Bristol-Myers Squibb Major Business
Table 9. Bristol-Myers Squibb Autacoids and Related Drugs Product and Services
Table 10. Bristol-Myers Squibb Autacoids and Related Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. APP Pharma Basic Information, Manufacturing Base and Competitors
Table 12. APP Pharma Major Business
Table 13. APP Pharma Autacoids and Related Drugs Product and Services
Table 14. APP Pharma Autacoids and Related Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 16. Abbott Laboratories Major Business
Table 17. Abbott Laboratories Autacoids and Related Drugs Product and Services
Table 18. Abbott Laboratories Autacoids and Related Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Sanofi Basic Information, Manufacturing Base and Competitors
Table 20. Sanofi Major Business
Table 21. Sanofi Autacoids and Related Drugs Product and Services
Table 22. Sanofi Autacoids and Related Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Chattem Basic Information, Manufacturing Base and Competitors
Table 24. Chattem Major Business
Table 25. Chattem Autacoids and Related Drugs Product and Services
Table 26. Chattem Autacoids and Related Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Xanodyne Basic Information, Manufacturing Base and Competitors
Table 28. Xanodyne Major Business
Table 29. Xanodyne Autacoids and Related Drugs Product and Services
Table 30. Xanodyne Autacoids and Related Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 32. AstraZeneca Major Business
Table 33. AstraZeneca Autacoids and Related Drugs Product and Services
Table 34. AstraZeneca Autacoids and Related Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Hospira Basic Information, Manufacturing Base and Competitors
Table 36. Hospira Major Business
Table 37. Hospira Autacoids and Related Drugs Product and Services
Table 38. Hospira Autacoids and Related Drugs Sales (K Units), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Autacoids and Related Drugs Sales by Manufacturer (2019-2021e) & (K Units)
Table 40. Global Autacoids and Related Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Autacoids and Related Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Autacoids and Related Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Autacoids and Related Drugs Production Site of Key Manufacturer
Table 44. Global Autacoids and Related Drugs Sales by Region (2016-2021e) & (K Units)
Table 45. Global Autacoids and Related Drugs Sales by Region (2021-2026) & (K Units)
Table 46. Global Autacoids and Related Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 47. Global Autacoids and Related Drugs Revenue by Region (2021-2026) & (USD Million)
Table 48. Global Autacoids and Related Drugs Sales by Type (2016-2021e) & (K Units)
Table 49. Global Autacoids and Related Drugs Sales by Type (2021-2026) & (K Units)
Table 50. Global Autacoids and Related Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 51. Global Autacoids and Related Drugs Revenue by Type (2021-2026) & (USD Million)
Table 52. Global Autacoids and Related Drugs Price by Type (2016-2021e) & (USD/Pcs)
Table 53. Global Autacoids and Related Drugs Price by Type (2021-2026) & (USD/Pcs)
Table 54. Global Autacoids and Related Drugs Sales by Application (2016-2021e) & (K Units)
Table 55. Global Autacoids and Related Drugs Sales by Application (2021-2026) & (K Units)
Table 56. Global Autacoids and Related Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 57. Global Autacoids and Related Drugs Revenue by Application (2021-2026) & (USD Million)
Table 58. Global Autacoids and Related Drugs Price by Application (2016-2021e) & (USD/Pcs)
Table 59. Global Autacoids and Related Drugs Price by Application (2021-2026) & (USD/Pcs)
Table 60. North America Autacoids and Related Drugs Sales by Country (2016-2021e) & (K Units)
Table 61. North America Autacoids and Related Drugs Sales by Country (2021-2026) & (K Units)
Table 62. North America Autacoids and Related Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 63. North America Autacoids and Related Drugs Revenue by Country (2021-2026) & (USD Million)
Table 64. North America Autacoids and Related Drugs Sales by Type (2016-2021e) & (K Units)
Table 65. North America Autacoids and Related Drugs Sales by Type (2021-2026) & (K Units)
Table 66. North America Autacoids and Related Drugs Sales by Application (2016-2021e) & (K Units)
Table 67. North America Autacoids and Related Drugs Sales by Application (2021-2026) & (K Units)
Table 68. Europe Autacoids and Related Drugs Sales by Country (2016-2021e) & (K Units)
Table 69. Europe Autacoids and Related Drugs Sales by Country (2021-2026) & (K Units)
Table 70. Europe Autacoids and Related Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 71. Europe Autacoids and Related Drugs Revenue by Country (2021-2026) & (USD Million)
Table 72. Europe Autacoids and Related Drugs Sales by Type (2016-2021e) & (K Units)
Table 73. Europe Autacoids and Related Drugs Sales by Type (2021-2026) & (K Units)
Table 74. Europe Autacoids and Related Drugs Sales by Application (2016-2021e) & (K Units)
Table 75. Europe Autacoids and Related Drugs Sales by Application (2021-2026) & (K Units)
Table 76. Asia-Pacific Autacoids and Related Drugs Sales by Region (2016-2021e) & (K Units)
Table 77. Asia-Pacific Autacoids and Related Drugs Sales by Region (2021-2026) & (K Units)
Table 78. Asia-Pacific Autacoids and Related Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 79. Asia-Pacific Autacoids and Related Drugs Revenue by Region (2021-2026) & (USD Million)
Table 80. Asia-Pacific Autacoids and Related Drugs Sales by Type (2016-2021e) & (K Units)
Table 81. Asia-Pacific Autacoids and Related Drugs Sales by Type (2021-2026) & (K Units)
Table 82. Asia-Pacific Autacoids and Related Drugs Sales by Application (2016-2021e) & (K Units)
Table 83. Asia-Pacific Autacoids and Related Drugs Sales by Application (2021-2026) & (K Units)
Table 84. South America Autacoids and Related Drugs Sales by Country (2016-2021e) & (K Units)
Table 85. South America Autacoids and Related Drugs Sales by Country (2021-2026) & (K Units)
Table 86. South America Autacoids and Related Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 87. South America Autacoids and Related Drugs Revenue by Country (2021-2026) & (USD Million)
Table 88. South America Autacoids and Related Drugs Sales by Type (2016-2021e) & (K Units)
Table 89. South America Autacoids and Related Drugs Sales by Type (2021-2026) & (K Units)
Table 90. South America Autacoids and Related Drugs Sales by Application (2016-2021e) & (K Units)
Table 91. South America Autacoids and Related Drugs Sales by Application (2021-2026) & (K Units)
Table 92. Middle East & Africa Autacoids and Related Drugs Sales by Country (2016-2021e) & (K Units)
Table 93. Middle East & Africa Autacoids and Related Drugs Sales by Country (2021-2026) & (K Units)
Table 94. Middle East & Africa Autacoids and Related Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 95. Middle East & Africa Autacoids and Related Drugs Revenue by Country (2021-2026) & (USD Million)
Table 96. Middle East & Africa Autacoids and Related Drugs Sales by Type (2016-2021e) & (K Units)
Table 97. Middle East & Africa Autacoids and Related Drugs Sales by Type (2021-2026) & (K Units)
Table 98. Middle East & Africa Autacoids and Related Drugs Sales by Application (2016-2021e) & (K Units)
Table 99. Middle East & Africa Autacoids and Related Drugs Sales by Application (2021-2026) & (K Units)
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Autacoids and Related Drugs Typical Distributors
Table 103. Autacoids and Related Drugs Typical Customers
List of Figures
Figure 1. Autacoids and Related Drugs Picture
Figure 2. Global Autacoids and Related Drugs Sales Market Share by Type in 2020
Figure 3. Polypeptides
Figure 4. Decarboxylated Amino Acids
Figure 5. Eicosanoids
Figure 6. Global Autacoids and Related Drugs Sales Market Share by Application in 2020
Figure 7. Allergies
Figure 8. Inflammation
Figure 9. Gastric Acid Secretion
Figure 10. Neuroendocrine Regulation
Figure 11. Chronic Pain
Figure 12. Cardiovascular Diseases
Figure 13. Gastrointestinal Diseases
Figure 14. Global Autacoids and Related Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 15. Global Autacoids and Related Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. United States Autacoids and Related Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Canada Autacoids and Related Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Mexico Autacoids and Related Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Germany Autacoids and Related Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. France Autacoids and Related Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. United Kingdom Autacoids and Related Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Russia Autacoids and Related Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Italy Autacoids and Related Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. China Autacoids and Related Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Japan Autacoids and Related Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Korea Autacoids and Related Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. India Autacoids and Related Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Southeast Asia Autacoids and Related Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Australia Autacoids and Related Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Brazil Autacoids and Related Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Egypt Autacoids and Related Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Saudi Arabia Autacoids and Related Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. South Africa Autacoids and Related Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Turkey Autacoids and Related Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Global Autacoids and Related Drugs Sales (2016-2026) & (K Units)
Figure 36. Global Autacoids and Related Drugs Production Capacity (2016-2026) & (K Units)
Figure 37. Global Autacoids and Related Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 38. Autacoids and Related Drugs Market Drivers
Figure 39. Autacoids and Related Drugs Market Restraints
Figure 40. Autacoids and Related Drugs Market Trends
Figure 41. Global Autacoids and Related Drugs Sales Market Share by Manufacturer in 2020
Figure 42. Global Autacoids and Related Drugs Revenue Market Share by Manufacturer in 2020
Figure 43. Autacoids and Related Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 44. Top 3 Autacoids and Related Drugs Manufacturer (Revenue) Market Share in 2020
Figure 45. Top 6 Autacoids and Related Drugs Manufacturer (Revenue) Market Share in 2020
Figure 46. Global Autacoids and Related Drugs Sales Market Share by Region (2016-2026)
Figure 47. Global Autacoids and Related Drugs Revenue Market Share by Region (2016-2026)
Figure 48. North America Autacoids and Related Drugs Revenue (2016-2026) & (USD Million)
Figure 49. Europe Autacoids and Related Drugs Revenue (2016-2026) & (USD Million)
Figure 50. Asia-Pacific Autacoids and Related Drugs Revenue (2016-2026) & (USD Million)
Figure 51. South America Autacoids and Related Drugs Revenue (2016-2026) & (USD Million)
Figure 52. Middle East & Africa Autacoids and Related Drugs Revenue (2016-2026) & (USD Million)
Figure 53. Global Autacoids and Related Drugs Sales Market Share by Type (2016-2026)
Figure 54. Global Autacoids and Related Drugs Revenue Market Share by Type (2016-2026)
Figure 55. Global Autacoids and Related Drugs Price by Type (2016-2026) & (USD/Pcs)
Figure 56. Global Autacoids and Related Drugs Sales Market Share by Application (2016-2026)
Figure 57. Global Autacoids and Related Drugs Revenue Market Share by Application (2016-2026)
Figure 58. Global Autacoids and Related Drugs Price by Application (2016-2026) & (USD/Pcs)
Figure 59. North America Autacoids and Related Drugs Sales Market Share by Country (2016-2026)
Figure 60. North America Autacoids and Related Drugs Revenue Market Share by Country (2016-2026)
Figure 61. North America Autacoids and Related Drugs Sales Market Share by Type (2016-2026)
Figure 62. North America Autacoids and Related Drugs Sales Market Share by Application (2016-2026)
Figure 63. Europe Autacoids and Related Drugs Sales Market Share by Country (2016-2026)
Figure 64. Europe Autacoids and Related Drugs Revenue Market Share by Country (2016-2026)
Figure 65. Europe Autacoids and Related Drugs Sales Market Share by Type (2016-2026)
Figure 66. Europe Autacoids and Related Drugs Sales Market Share by Application (2016-2026)
Figure 67. Asia-Pacific Autacoids and Related Drugs Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Autacoids and Related Drugs Revenue Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Autacoids and Related Drugs Sales Market Share by Region (2016-2026)
Figure 70. Asia-Pacific Autacoids and Related Drugs Sales Market Share by Application (2016-2026)
Figure 71. South America Autacoids and Related Drugs Sales Market Share by Country (2016-2026)
Figure 72. South America Autacoids and Related Drugs Revenue Market Share by Country (2016-2026)
Figure 73. South America Autacoids and Related Drugs Sales Market Share by Type (2016-2026)
Figure 74. South America Autacoids and Related Drugs Sales Market Share by Application (2016-2026)
Figure 75. Middle East & Africa Autacoids and Related Drugs Sales Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Autacoids and Related Drugs Revenue Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Autacoids and Related Drugs Sales Market Share by Type (2016-2026)
Figure 78. Middle East & Africa Autacoids and Related Drugs Sales Market Share by Application (2016-2026)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
加齢黄斑変性症遺伝子治療の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Macular degeneration is a condition in which, macula, a part of the retina, gets damaged or deteriorated. This condition usually affects individuals who are aged 50 years and above and therefore, it is called age-related macular degeneration (AMD). AMD is the leading cause of vision loss and is dire…- 糖尿病と関連疾患に対する幹細胞療法の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Diabetes is the metabolic disorder that is associated with the glucose level in the blood. It is mainly divided into two types, insulin-dependent diabetes mellitus or juvenile onset (type 1) and non-insulin-dependent diabetes mellitus, or adult-onset diabetes (type 2). Scope of the Report: This repo…
- 内燃機関および関連フィルターの世界市場予測 2023年：メーカー別、地域別、種類・用途別 An internal combustion engine (ICE) is a heat engine where the combustion of a fuel occurs with an oxidizer (usually air) in a combustion chamber that is an integral part of the working fluid flow circuit. In an internal combustion engine, the expansion of the high-temperature and high-pressure gase…
- 世界の遺伝子組換え型エリスロポエチン治療薬市場 2021：企業別、地域別、種類・用途別 The Recombinant Erythropoietin Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 世界のエポプロステノールナトリウム薬品市場 2021：企業別、地域別、種類・用途別 The Epoprostenol Sodium Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…